 |
|
|
| |
Sofosbuvir + Ribavirin for 12 or 24 Weeks Is Safe and Effective in Adolescents With Genotype 2 or Genotype 3 Chronic Hepatitis C Infection
|
| |
| |
Reported by Jules Levin
AASLD Nov 11-15 2016 Boston, MA
Kathleen Schwarz,1 Philip Rosenthal,2 Regino Gonzalez-Peralta,3 Maureen M. Jonas,4 William Balistreri,5 Chuan-Hao Lin,6 Winita Hardikar,7 Kathryn Kersey,8
Bittoo Kanwar,8 Diana M. Brainard,8 Benedetta Massetto,8 Yanni Zhu,8 Ashley Prasse,8 Brian Kirby,8 Ronen Arnon,9 Karen F. Murray,10 Stefan Wirth11
1The Johns Hopkins University School of Medicine, Baltimore, MD; 2University of California San Francisco; 3University of Florida, Gainesville; 4Boston Children's Hospital, Boston, MA; 5Cincinnati Children's Hospital Medical Center, Cincinnati, OH; 6Children's Hospital Los Angeles, CA;
7The Royal Children's Hospital Melbourne, Victoria, Australia; 8Gilead Sciences, Inc., Foster City, CA; 9The Mount Sinai Hospital, New York, NY; 10Seattle Children's Hospital, Seattle, WA; 11Helios Medical Center, Witten/Herdecke University, Wuppertal, Germany
|
| |
|
|
|
|
|
